This fluorinated quinoline derivative (CAS 112022-64-9) serves as a premium building block in pharmaceutical and advanced material synthesis. The trifluoromethyl group enhances both metabolic stability and lipophilicity compared to non-fluorinated analogs.
Parameter | Specification | Analog Compound | Competitive Advantage |
---|---|---|---|
Purity | ≥99.5% (HPLC) | 98% typical | Superior reaction efficiency |
Solubility | DMSO >50mg/mL | ~30mg/mL | Better formulation flexibility |
Thermal Stability | Stable up to 250°C | 220°C decomposition | Enhanced process safety |
Critical component in:
Typical reaction conditions:
Step | Conditions | Yield |
---|---|---|
Cyclization | DMAc, 120°C, 8h | 82-85% |
Fluorination | CuI catalyst, 80°C | 91% |
Batch process optimization parameters:
Challenge: Develop brain-penetrant EGFR inhibitors
Solution: Utilized compound's CF3 group for blood-brain barrier penetration
Outcome: 3 lead compounds with IC50 < 10nM
Challenge: Create stable blue OLED emitters
Solution: Incorporated as electron-deficient moiety
Result: 18% EQE improvement vs. baseline
Available modifications:
Contact our technical team:
Email: info@vivalr.com
Tel: (86) 15866781826
This is William, CEO of fousi chemical Chemical Co., Ltd.
Welcome to visit our factory . As the top chemical manufacturer, we have been striving for product quality, innovation , R&D, and customer service for the past 7 years. In the next 10 years or even longer, we are committed to becoming the most reliable chemical supplier in the world , creating a well-known international brand trusted by customers, with the spirit of “one meter wide, ten thousand meters deep”, we continue to focus on product research and development, continue to focus on customer service, continue to improve the supply chain service system, to create a professional chemical supply service team, to achieve win-win long-term cooperation. Please feel free to contact us if you have any questions.